VCP and cancer: We also demonstrate that GCN2 signalling represents a mechanism by which cancer cells can cope with the combined action of VCP/p97 inhibition and nutrient deprivation (Fig. 6), by attenuating stress signalling and cell death, and by modulating ERK signalling, autophagy, and glycolytic metabolism.